dag3
Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
dag3 [2020/02/12 08:37] – trynke | dag3 [2025/02/05 13:49] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== DAG3 ====== | ====== DAG3 ====== | ||
- | DAG3 is one of Lifelines' | + | DAG3 is one of Lifelines' |
===== Background ===== | ===== Background ===== | ||
Line 10: | Line 10: | ||
===== Subcohort ===== | ===== Subcohort ===== | ||
- | A total of 9500 participants were included in the DAG3 dataset: | + | A total of approximately |
* 700 were [[children]] aged 8-17 years | * 700 were [[children]] aged 8-17 years | ||
* 400 participants were also included in the ([[DEEP]]) dataset | * 400 participants were also included in the ([[DEEP]]) dataset | ||
- | * microbiome collection sites were more diverse | ||
* ~9000 participants were genotyped in the [[UGLI]] project. | * ~9000 participants were genotyped in the [[UGLI]] project. | ||
- | Metagenomic sequencing of the Lifelines DAG3 samples | + | Metagenomic sequencing of the Lifelines DAG3 samples |
(2018). Pharmacomicrobiomics: | (2018). Pharmacomicrobiomics: | ||
- | Besides the samples used to generate the microbiome data, questionnaires were also sent to participants to gather phenotypic data on GI health symptoms by means of [[Functional bowel symptoms (Rome III)|Rome III]] criteria questionnaire (Longstreth etal 2006) and the Bristol Stool Form Scale (O’Donnell etal 1990). | + | Besides the samples used to generate the microbiome data, questionnaires were also sent to participants to gather phenotypic data on gastrointestinal |
===== Study protocol ===== | ===== Study protocol ===== | ||
Line 27: | Line 26: | ||
* Signed DAG3 IC available | * Signed DAG3 IC available | ||
* Registration of participant | * Registration of participant | ||
- | * 1 x throat and 1 x nose swab with amysmedium | + | * 1 x throat and 1 x nose swab with amies liquid medium |
- | * 1 x throat and 1 x nose e-nat-swab with presercation | + | * 1 x throat and 1 x nose e-nat-swab with preservation |
* Swabs are stored in refrigerator at the visit location and processed/ | * Swabs are stored in refrigerator at the visit location and processed/ | ||
* Face-to-face instruction of stool collection | * Face-to-face instruction of stool collection | ||
Line 39: | Line 38: | ||
Participants received a package with the following materials: | Participants received a package with the following materials: | ||
* 3 precoded cups to put stool in by means of a provided pipet | * 3 precoded cups to put stool in by means of a provided pipet | ||
- | * 2 tubes with amysmedium | + | * 2 tubes with amies liquid medium |
* a nontransparent bag to store the samples in the home freezer immediately after collection | * a nontransparent bag to store the samples in the home freezer immediately after collection | ||
* participants were instructed to fill in a questionnaire and stool diary in the week of stool collection | * participants were instructed to fill in a questionnaire and stool diary in the week of stool collection | ||
Line 45: | Line 44: | ||
===== Sample processing ===== | ===== Sample processing ===== | ||
- | * Swabs containing | + | * Swabs containing |
- | * Stool samples were taken in between 16:30 and 19:00 by hired personnel and transported to the Lifelines lab in cool boxes containing cooling elements. Collectors asked participants at home if they filled all three cups and two tubes and if not, the reason for an incomplete collection. At the Lifelines lab all cups and tubes are stored at -80C. | + | * Stool samples were taken in between 16:30 and 19:00 by hired personnel and transported to the Lifelines lab in refrigerated |
- | * blood samples were collected in a PAXgene tube, by means of a ‘butterfly needle’. | + | * blood samples were collected in a PAXgene tube, by means of a ‘butterfly needle’. |
===== Collected samples ===== | ===== Collected samples ===== | ||
- | The following additional samples have been collected for DAG3: | + | The following additional samples have been collected for DAG3 from approximately 9500 participants: |
* 9535 e-nat nose samples | * 9535 e-nat nose samples | ||
- | | + | * 28612 nose swab aliquots (glycerol)* |
- | | + | |
* 9425 throat e-nat samples | * 9425 throat e-nat samples | ||
- | | + | * 28245 throat swab aliquots (glycerol)* |
- | | + | * 16827 feces swab samples* |
- | * 16827 feces swab samples | + | * 25376 feces cryo samples* |
- | * 25376 feces cryo samples | + | * 8931 PAXgene |
- | * 8931 paxgene | + | |
* 5400 complete diaries | * 5400 complete diaries | ||
* 2482 incomplete diaries (i.e. may miss one or more days) | * 2482 incomplete diaries (i.e. may miss one or more days) | ||
+ | *Multiple samples from a single participant, | ||
+ | ===== Papers based on DAG3 ===== | ||
+ | * Gacesa, R et al. (2022) Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739 |
dag3.1581496671.txt.gz · Last modified: (external edit)